PRIMARY BILIARY CHOLANGITIS
Clinical trials for PRIMARY BILIARY CHOLANGITIS explained in plain language.
Never miss a new study
Get alerted when new PRIMARY BILIARY CHOLANGITIS trials appear
Sign up with your email to follow new studies for PRIMARY BILIARY CHOLANGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to protect livers from scarring disease
Disease control Not yet recruitingThis study is testing whether a drug called saroglitazar magnesium can help people with primary biliary cholangitis (PBC), a chronic liver disease. It will compare the drug to a placebo in about 386 adults who are already on standard treatment. The main goal is to see if the drug…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
New hope for liver disease patients who Don't respond to standard treatment
Disease control Not yet recruitingThis study is testing whether a medication called saroglitazar magnesium can help control primary biliary cholangitis, a chronic liver disease. The trial will involve 89 adults who either don't respond well to or can't tolerate the standard treatment. Participants will receive ei…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE3 • Sponsor: Zydus Therapeutics Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Simple scan could spare patients from uncomfortable tests
Diagnosis Not yet recruitingThis study is testing whether measuring spleen stiffness, in addition to standard liver scans, can better predict complications in people with Primary Biliary Cholangitis (PBC), a chronic liver disease. Researchers will follow 125 adult patients already receiving standard care an…
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: NA • Sponsor: Universitair Ziekenhuis Brussel • Aim: Diagnosis
Last updated Mar 30, 2026 14:35 UTC
-
New drug trial targets debilitating itch in liver disease patients
Symptom relief Not yet recruitingThis study is testing whether an investigational drug called TH104 can safely reduce severe itching in people with primary biliary cholangitis (PBC), a chronic liver disease. Forty participants with moderate to severe itching will receive either TH104 or a placebo for six weeks, …
Matched conditions: PRIMARY BILIARY CHOLANGITIS
Phase: PHASE2 • Sponsor: Tharimmune Inc • Aim: Symptom relief
Last updated Apr 01, 2026 14:41 UTC